Crescita Therapeutics Inc.
CRRTF
$0.56
$0.00-0.85%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -63.55% | -193.29% | -5.22% | 188.82% | -461.28% |
| Total Depreciation and Amortization | -5.60% | 5.74% | 9.29% | 3.70% | -5.64% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -24.45% | 149.12% | -559.97% | -32.32% | -225.73% |
| Change in Net Operating Assets | 73.83% | -46.41% | 167.41% | -847.69% | -87.19% |
| Cash from Operations | -65.78% | -64.96% | 38,809.09% | 99.38% | -136.36% |
| Capital Expenditure | 64.75% | 93.86% | -385.03% | -167.17% | 81.76% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -60.64% | -- | -- | -- | -- |
| Cash from Investing | -58.21% | 110.12% | -385.03% | -167.17% | 81.76% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 64.85% | -39.83% | -1.72% | 0.00% | -2.65% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | 100.00% | -105.08% | -37.21% | 44.16% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 72.96% | 11.12% | -37.15% | -14.17% | 35.36% |
| Foreign Exchange rate Adjustments | 187.83% | -243.75% | 286.05% | -304.76% | -94.34% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -50.47% | 114.44% | 135.17% | 50.03% | -185.85% |